Intrinsic Laryngeal Muscles and Potential Treatments for Skeletal Muscle-Wasting Disorders

Editorial

Austin J Otolaryngol. 2014;1(1): 2.

Intrinsic Laryngeal Muscles and Potential Treatments for Skeletal Muscle-Wasting Disorders

Feng X1*, D Clark Files2,3 and T Zhang4

1Department of Otolaryngology, Wake Forest School of Medicine, USA

2Internal Medicine-Pulmonary, Critical Care, Allergy and Immunology, Wake Forest School of Medicine, USA

3Wake Forest Critical Illness, Injury and Recovery Research Center, Wake Forest School of Medicine, USA

4Internal Medicine-Gerontology, Wake Forest School of Medicine, USA

*Corresponding author: Feng X, Department of Otolaryngology, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem

Received: July 22, 2014; Accepted: July 27, 2014; Published: July 31, 2014

Laryngeal muscles are groups of muscle pairs within (intrinsic laryngeal muscles) and outside (extrinsic laryngeal muscles) the larynx. They contribute to movement of the vocal folds inside the larynx and positioning of the whole larynx within the trachea. The intrinsic laryngeal muscles originate and insert on the larynx, move the arytenoid cartilage, and adjust the tension of the vocal folds and ligaments. Thus, these muscles play an important role in voice production, breathing, and vocal fold closure during swallowing. These intrinsic laryngeal muscles include the posterior cricoarytenoid (PCA), transverse arytenoid, oblique arytenoid, lateral cricoarytenoid, thyroarytenoid (TA), and cricothyroid (CT) muscles. They are innervated by the vagus nerve and share the internal branch of the superior laryngeal nerve as the sensory innervations. Most of these muscles share the recurrent laryngeal nerve as the source for motor innervation, except the CT muscle, which receives motor innervation via the external branch of superior laryngeal nerve.

The PCA, TA, and CT muscles are the most commonly studied intrinsic laryngeal muscles in terms of myosin heavy chain (MyHC) isoforms, function, innervation, neuromuscular junction morphology, and mitochondrial content [1-8]. These characteristics determine the differences in muscle force, velocity, and strength among the intrinsic laryngeal muscles and between them and limb muscles.

One fascinating aspect of the intrinsic laryngeal muscles is that some of them are spared from certain muscle wasting disorders. For example, the intrinsic laryngeal muscles, except for the CT muscle, are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy and congenital muscular dystrophy type 1A [9- 12]. In this model, the CT muscle and extrinsic laryngeal muscle show myofibrillar damage and myopathy similar to the diaphragm and limb muscles [9,10]. In addition, the CT muscle is more severely affected by myasthenia gravis than the TA and PCA muscles, as determined by electromyography [13]. We have shown that the PCA, but not the CT muscle, is spared from muscle wasting in a murine model of the Acute Respiratory Distress Syndrome (ARDS) and Intensive Care Unit-Acquired Weakness (ICUAW) [14].

The mechanisms underlying the sparing of intrinsic laryngeal muscles from muscle wasting are incompletely understood. Elucidating these mechanisms is necessary to develop better treatments for a variety of muscle degenerative diseases.

Muscle functional and morphological characteristics depend on their fiber type and motor innervation, which are modulated by specific genes [15,16]. MyHC, the motor protein of muscle thick filaments, is predominantly expressed in each individual muscle fiber and defines specific muscle fiber properties and responses in various muscle diseases. In addition to the intrinsic laryngeal muscles, other craniofacial muscles, such as the extraocular muscles (EOM), are also spared from some muscle wasting disorders [17-20]. In addition, the masticatory muscles are spared from ICUAW in humans and experimental models [21]. Although the mechanisms are not fully understood, the distinctive gene expression profile in the EOM and masticatory versus limb muscles indicates a highly complex and muscle-specific/developmental response that may protect these muscles [21,22].

The intrinsic laryngeal muscles share some unique MyHC expression and innervation, and the mechanisms of muscle sparing between these groups may be similar. Specifically, both the PCA and EOM contain extraocular myosin heavy chain (MyHC-EO) protein [14,23], which is absent in the limb muscles and some intrinsic laryngeal muscles (e.g., the CT muscle). Second, these two muscles have multiple innervation patterns in a single muscle fiber [2,24- 27] compared to other limb muscles, which have a single pattern. Third, utrophin mediates muscle protection from dystrophinophathy in both intrinsic laryngeal and EOM [28,29]. Utrophin, a protein expressed within skeletal muscle tissue, neuromuscular synapse and myotendinous junctions, is necessary for normal membrane maintenance, and for the stability and function of the acetylcholine receptors (see [30] for a review).

Given that the PCA muscle and the EOM share some structural characteristics, the mechanisms underlying their sparing from muscular diseases should be similar. In our mouse model of acute lung injury, the PCA (but not CT and limb muscle) is spared from the atrophy mediated by the E3 ubiquitin ligase muscle ring finger-1 protein (MuRF1) [14]. MuRF1 was first identified in flowing transcript profiling in fasting and immobilization models of rodent muscle atrophy [31]. In our mouse model of acute lung injury, it is responsible for limb muscle atrophy in the early phase of muscle wasting [32]. We found that, compared to the CT and limb muscles, the PCA muscle has lower levels of MuRF1 and lacks MuRF1 upregulation lung injury. In addition, MyHC-EO composition is higher in the PCA muscle (27%) versus the EOM (14%) (unpublished data).

MyHC-EO, encoded by the MYH13 gene, is supposed to be the fastest MHC isoform but is functionally similar to the slower isoforms [33,34]. The PCA and CT muscles have similar MyHC composition in our mouse model except for the high expression of MyHC-EO in the PCA muscle. We hypothesize that MyHC-EO and its related cell signaling may play an important role in the protection of PCA muscle from atrophy in critical illness. Further exploration of the MyHC-EO and its relationship to MuRF1 may lead to a deeper understanding of how these muscles function, and thus may identify future therapeutic targets for muscle wasting disorders.

In summary, further studies to explore why intrinsic laryngeal muscles are spared from muscle wasting disorders may facilitate the development of novel strategies for the prevention and treatment of muscle wasting in a variety of clinical scenarios.

Acknowledgement

The authors thank Dr. Osvaldo Delbono (Internal Medicine- Gerontology) and Karen Potvin Klein, MA, ELS (Biomedical Research Services and Administration), Wake Forest University Health Sciences, for their helpful discussion and comments.

References

  1. Toniolo L, Macchi V, Porzionato A, Paoli A, Marchese-Ragona R, De Caro R, et al. Myosin heavy chain isoforms in human laryngeal muscles: an expression study based on gel electrophoresis. Int J Mol Med. 2008; 22: 375-379.
  2. Feng X, Zhang T, Ralston E, Ludlow CL. Differences in neuromuscular junctions of laryngeal and limb muscles in rats. Laryngoscope. 2012; 122: 1093-1098.
  3. D'Antona G, Megighian A, Bortolotto S, Pellegrino MA, Marchese-Ragona R, Staffieri A, et al. Contractile properties and myosin heavy chain isoform composition in single fibre of human laryngeal muscles. J Muscle Res Cell Motil. 2002; 23: 187-195.
  4. Shiotani A, Westra WH, Flint PW. Myosin heavy chain composition in human laryngeal muscles. Laryngoscope. 1999; 109: 1521-1524.
  5. Bendiksen FS, Dahl HA, Teig E. Innervation pattern of different types of muscle fibres in the human thyroarytenoid muscle. Acta Otolaryngol. 1981; 91: 391-397.
  6. Périé S, St Guily JL, Sebille A. Comparison of perinatal and adult multi-innervation in human laryngeal muscle fibers. Ann Otol Rhinol Laryngol. 1999; 108: 683-688.
  7. Périé S, St Guily JL, Callard P, Sebille A. Innervation of adult human laryngeal muscle fibers. J Neurol Sci. 1997; 149: 81-86.
  8. Hinrichsen C, Dulhunty A. The contractile properties, histochemistry, ultrastructure and electrophysiology of the cricothyroid and posterior cricoarytenoid muscles in the rat. J Muscle Res Cell Motil. 1982; 3: 169-190.
  9. Marques MJ, Ferretti R, Vomero VU, Minatel E, Neto HS. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve. 2007; 35: 349-353.
  10. Smythe GM. Dystrophic pathology in the intrinsic and extrinsic laryngeal muscles in the mdx mouse. J Otolaryngol Head Neck Surg. 2009; 38: 323-336.
  11. Thomas LB, Joseph GL, Adkins TD, Andrade FH, Stemple JC. Laryngeal muscles are spared in the dystrophin deficient mdx mouse. J Speech Lang Hear Res. 2008; 51: 586-595.
  12. Häger M, Durbeej M. Intrinsic laryngeal muscles are spared from degeneration in the dy3K/dy3K mouse model of congenital muscular dystrophy type 1A. Muscle Nerve. 2009; 39: 91-94.
  13. Xu W, Han D, Hou L, Hu R, Wang L. Clinical and electrophysiological characteristics of larynx in myasthenia gravis. Ann Otol Rhinol Laryngol. 2009; 118: 656-661.
  14. Files DC, Xiao K, Zhang T, Liu C, Qian J, Zhao W, et al. The posterior cricoarytenoid muscle is spared from MuRF1-mediated muscle atrophy in mice with acute lung injury. PLoS One. 2014; 9: e87587.
  15. Wells L, Edwards KA, Bernstein SI. Myosin heavy chain isoforms regulate muscle function but not myofibril assembly. EMBO J. 1996; 15: 4454-4459.
  16. Swank DM, Wells L, Kronert WA, Morrill GE, Bernstein SI. Determining structure/function relationships for sarcomeric myosin heavy chain by genetic and transgenic manipulation of Drosophila. Microsc Res Tech. 2000; 50: 430-442.
  17. Kallestad KM, Hebert SL, McDonald AA, Daniel ML, Cu SR, McLoon LK, et al. Sparing of extraocular muscle in aging and muscular dystrophies: a myogenic precursor cell hypothesis. Exp Cell Res. 2011; 317: 873-885.
  18. Kaminski HJ, al-Hakim M, Leigh RJ, Katirji MB, Ruff RL. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann Neurol. 1992; 32: 586-588.
  19. Porter JD, Karathanasis P. Extraocular muscle in merosin-deficient muscular dystrophy: cation homeostasis is maintained but is not mechanistic in muscle sparing. Cell Tissue Res. 1998; 292: 495-501.
  20. McMullen CA, Ferry AL, Gamboa JL, Andrade FH, Dupont-Versteegden EE. Age-related changes of cell death pathways in rat extraocular muscle. Exp Gerontol. 2009; 44: 420-425.
  21. Aare S, Ochala J, Norman HS, Radell P, Eriksson LI, Goransson H, et al. Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model. Physiol Genomics. 2011; 43: 1334-1350.
  22. Porter JD, Khanna S, Kaminski HJ, Rao JS, Merriam AP, Richmonds CR, et al. Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci U S A. 2001; 98: 12062-12067.
  23. Zhou Y, Liu D, Kaminski HJ. Myosin heavy chain expression in mouse extraocular muscle: more complex than expected. Invest Ophthalmol Vis Sci. 2010; 51: 6355-6363.
  24. Périé S, St Guily JL, Sebille A. Comparison of perinatal and adult multi-innervation in human laryngeal muscle fibers. Ann Otol Rhinol Laryngol. 1999; 108: 683-688.
  25. Périé S, St Guily JL, Callard P, Sebille A. Innervation of adult human laryngeal muscle fibers. J Neurol Sci. 1997; 149: 81-86.
  26. Rashed RM, El-Alfy SH. Ultrastructural organization of muscle fiber types and their distribution in the rat superior rectus extraocular muscle. Acta Histochem. 2012; 114: 217-225.
  27. Dimitrova DM, Allman BL, Shall MS, Goldberg SJ. Polyneuronal innervation of single muscle fibers in cat eye muscle: inferior oblique. J Neurophysiol. 2009; 101: 2815-2821.
  28. Porter JD, Rafael JA, Ragusa RJ, Brueckner JK, Trickett JI, Davies KE, et al. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Sci. 1998; 111 : 1801-1811.
  29. Ferretti R, Neto HS, Marques MJ. Expression of utrophin at dystrophin-deficient neuromuscular synapses of mdx mice: a study of protected and affected muscles. Anat Rec (Hoboken). 2011; 294: 283-286.
  30. Banks GB, Fuhrer C, Adams ME, Froehner SC. The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin/dystrophin-associated complex. J Neurocytol. 2003; 32: 709-726.
  31. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001; 294: 1704-1708.
  32. Files DC1, D'Alessio FR, Johnston LF, Kesari P, Aggarwal NR, Garibaldi BT . A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting. Am J Respir Crit Care Med. 2012; 185: 825-834.
  33. Bloemink MJ1, Deacon JC, Resnicow DI, Leinwand LA, Geeves MA . The superfast human extraocular myosin is kinetically distinct from the fast skeletal IIa, IIb, and IId isoforms. J Biol Chem. 2013; 288: 27469-27479.
  34. Resnicow DI1, Deacon JC, Warrick HM, Spudich JA, Leinwand LA . Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci U S A. 2010; 107: 1053-1058.

Download PDF

Citation: Feng X, D. Clark Files and Zhang T. Intrinsic Laryngeal Muscles and Potential Treatments for Skeletal Muscle-Wasting Disorders. Austin J Otolaryngol. 2014;1(1): 3. ISSN :2473-0645

Home
Journal Scope
Online First
Current Issue
Editorial Board
Instruction for Authors
Submit Your Article
Contact Us